These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 18263681
1. Longitudinal decline of diffusing capacity of the lung for carbon monoxide in community subjects with the PiMZ alpha1-antitrypsin phenotype. Silva GE, Guerra S, Keim S, Barbee RA, Sherrill DL. Chest; 2008 May; 133(5):1095-100. PubMed ID: 18263681 [Abstract] [Full Text] [Related]
2. A longitudinal study of alpha1-antitrypsin phenotypes and decline in FEV1 in a community population. Silva GE, Sherrill DL, Guerra S, Barbee RA. Chest; 2003 May; 123(5):1435-40. PubMed ID: 12740258 [Abstract] [Full Text] [Related]
6. Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population. McDonagh DJ, Nathan SP, Knudson RJ, Lebowitz MD. J Clin Invest; 1979 Feb; 63(2):299-309. PubMed ID: 311786 [Abstract] [Full Text] [Related]
13. The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency. Piitulainen E, Tanash HA. COPD; 2015 May; 12 Suppl 1():36-41. PubMed ID: 25938290 [Abstract] [Full Text] [Related]
16. Risk of hospital admission for obstructive pulmonary disease in alpha(1)-antitrypsin heterozygotes of phenotype PiMZ. Seersholm N, Wilcke JT, Kok-Jensen A, Dirksen A. Am J Respir Crit Care Med; 2000 Jan; 161(1):81-4. PubMed ID: 10619801 [Abstract] [Full Text] [Related]